glypican-4 Activators
Glypican-4 activators belong to a category of compounds that interact with a specific type of proteoglycan known as glypican-4. Glypicans are a family of heparan sulfate proteoglycans that are attached to the cell surface via a glycosylphosphatidylinositol (GPI) anchor, and they play a key role in the modulation of cell signaling by interacting with various growth factors and morphogens. There are six known glypicans in vertebrates, numbered glypican-1 through glypican-6, and glypican-4 is one of these structurally related core proteins. The activators of glypican-4 are molecules that can enhance or modulate the activity of glypican-4, affecting its ability to interact with signaling molecules. This interaction is crucial because glypican-4 can impact the way cells communicate and respond to their environment through the regulation of signaling pathways.
The structure of glypican-4 is characterized by a core protein to which several heparan sulfate glycosaminoglycan chains are attached. These chains are critical for its function, as they interact with a wide range of ligands, typically growth factors. Glypican-4 activators may influence the sulfation pattern of the heparan sulfate chains or the conformation of the core protein itself, thereby affecting the affinity and specificity of glypican-4-ligand interactions. The precise mechanism by which these activators work can vary, but they generally promote the functional activity of glypican-4, which can have significant effects on cellular processes. The modulation of glypican-4 activity by its activators can influence the distribution and availability of growth factors in the extracellular environment, thereby subtly shaping the signaling landscape that cells are exposed to. This modulation can have a profound impact on the regulation of cellular processes that are controlled by the signaling pathways in which glypican-4 is involved.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylate cyclase, increasing cAMP levels. Elevated cAMP enhances PKA activity, which can phosphorylate glypican-4, thus potentially increasing its functional activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can lead to phosphorylation of downstream effectors. This phosphorylation cascade can influence glypican-4 activity by altering its cellular context or interaction with signaling molecules. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that raises intracellular calcium levels, activating calmodulin-dependent kinase (CaMK), which could indirectly enhance glypican-4 activity through downstream signaling effects. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin activates the PI3K/Akt signaling pathway. Akt can phosphorylate various proteins that may interact with or modify glypican-4, thus enhancing its functional activity. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid modulates gene expression via retinoic acid receptors. This modulation can alter the expression of proteins that interact with or regulate glypican-4, thereby influencing its functional activity. | ||||||
Casein Kinase I Inhibitor, D4476 | 301836-43-1 | sc-202522 | 1 mg | $99.00 | 6 | |
D4476 is a casein kinase 1 (CK1) inhibitor. By inhibiting CK1, D4476 can alter Wnt/β-catenin signaling, potentially enhancing glypican-4 activity due to its role in modulating this pathway. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor. While it generally acts to inhibit PI3K, the resultant changes in downstream signaling can paradoxically enhance glypican-4 function by compensatory mechanisms within the cell. | ||||||